Prevalence of PVL-containing MRSA isolates among hospital staff nasal carriers

Laboratory Medicine

Volumn 42, Issue 5, 2011, Pages 283-286

  Lari, Abdolaziz Rastegar ^a   Pourmand, Mohammad Reza ^a   Moghadam, Solmaz Ohadian ^a   Abdossamadi, Zahra ^a   Namvar, Amirmorteza Ebrahimzadeh ^a   Asghari, Babak ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Methicillin resistant staphylococcus aureus; Nasal carriers; Panton valentine leukocidin

Indexed keywords

PANTON VALENTINE LEUKOCIDIN;

ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; DISEASE CARRIER; HOSPITAL PERSONNEL; HUMAN; IRAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; POLYMERASE CHAIN REACTION; PREVALENCE;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 79955540760     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMAN7HR6VJEA3NMR     Document Type: Article

References (52)

1. Fey PD, Saïd-Salim B, Rupp ME, et al. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003;47:196-203.
2. Enright MC, Robinson DA, Randle G, et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA. 2002;99:7687-7692.
3. Grundmann H, Aires-de-Sousa M, Boyce J, et al. Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. Lancet. 2006;368:874-885.
4. David MZ, Crawford SE, Boyle-Vavra S, et al. Contrasting pediatric and adult methicillin-resistant Staphylococcus aureus isolates. Emerg Infect Dis. 2006;12:631-637.
5. Holmes A, Ganner M, McGuane S, et al. Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: Frequency, characterization, and association with clinical disease. J Clin Microbiol. 2005;43:2384-2390.
6. Pourmand MR, Memariani M, Hoseini M, et al. High prevalence of sea gene among clinical isolates of Staphylococcus aureus in Tehran. AMI. 2009;47:357-361.
7. Gravet A, Colin DA, Keller D, et al. Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett. 1998;436:202-208.
8. Choorit W, Kaneko J, Muramoto K, et al. Existence of a new protein component with the same function as the LukF component of leukocidin or gamma-hemolysin and its gene in Staphylococcus aureus P83. FEBS Lett. 1995;357:260-264.
9. Kaneko J, Muramoto K, Kamio Y. Gene of LukF-PV-like component of Panton-Valentine leukocidin in Staphylococcus aureus P83 is linked with lukM. Biosci Biotechnol Biochem. 1997;61:541-544.
10. Havaei SA, Ohadian Moghadam S, Pourmand MR, et al. Prevalence of genes encoding bi-component leukocidins among clinical isolates of methicillin-resistant Staphylococcus aureus. Iranian J Publ Health. 2010;39:8-14.
11. Supersac G, Prevost G, Piemont Y. Sequencing of leucocidin R from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxins. Infect Immun. 1993;61:580-587.
12. Ruimy R, Maiga A, Armand-Lefevre L, et al. The carriage population of Staphylococcus aureus from Mali is composed of a combination of pandemic clones and the divergent Panton-Valentine leukocidin-positive genotype ST152. J Bacteriol. 2008;190:3962-3968.
13. Diep BA, Sensabaugh GF, Somboonna N, et al. Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin. J Clin Microbiol. 2004;42:2080-2084.
14. Zaoutis TE, Toltzis P, Chu J, et al. Clinical and molecular epidemiology of community-acquired methicillin-resistant Staphylococcus aureus infections among children with risk factors for health care-associated infection: 2001-2003. Pediatr Infect Dis J. 2006;25:343-348.
15. Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39:971-979.
16. von Eiff C, Becker K, Machka K, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med. 2001;344:11-16.
17. Weinstein HJ. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. N Engl J Med. 1959;260:1303-1308.
18. Luzar MA, Coles GA, Faller B, et al. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N Engl J Med. 1990;322:505-509.
19. Saderi H, Owlia P, Habibi M. Mupirocin resistance among Iranian isolates of Staphylococcus aureus. Med Sci Monit. 2008;14:210-213.
20. Nguyen MH, Kauffman CA, Goodman RP, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med. 1999;130:221-225.
21. Boelaert JR, Van Landuyt HW, Godard CA, et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant. 1993;8:235-239.
22. Kluytmans J. Reduction of surgical site infections in major surgery by elimination of nasal carriage of Staphylococcus aureus. J Hosp Infect. 1998;40(suppl B):S25-S29.
23. Pérez-Fontán M, García-Falcón T, Rosales M, et al. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: Long-term results. Am J Kidney Dis. 1993;22:708-712.
24. Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: Molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis. 2002;2:180-189.
25. Hollis RJ, Barr JL, Doebbeling BN, et al. Familial carriage of methicillin-resistant Staphylococcus aureus and subsequent infection in a premature neonate. Clin Infect Dis. 1995;21:328-332.
26. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med. 2005;352:1445-1453.
27. Yamasaki O, Kaneko J, Morizane S, et al. The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis. 2005;40:381-385.
28. O'Brien FG, Pearman JW, Gracey M, et al. Community strain of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak. J Clin Microbiol. 1999;37:2858-2862.
29. Wannet WJ, Heck ME, Pluister GN, et al. Panton-Valentine leukocidin positive MRSA in 2003: The Dutch situation. Euro Surveill. 2004;9:28-29.
30. Wagenlehner FM, Naber KG, Bambl E, et al. Management of a large healthcare-associated outbreak of Panton-Valentine leucocidin-positive meticillin-resistant Staphylococcus aureus in Germany. J Hosp Infect. 2007;67:114-120.
31. Munckhof WJ, Nimmo GR, Schooneveldt JM, et al. Nasal carriage of Staphylococcus aureus, including community-associated methicillin-resistant strains, in Queensland adults. Clin Microbiol Infect. 2009;15:149-155.
32. Raab U, Kahlau D, Wagenlehner F, et al. Prevalence of and risk factors for carriage of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus among residents and staff of a German nursing home. Infect Control Hosp Epidemiol. 2006;27:208-211.
33. Köck R, Brakensiek L, Mellmann A, et al. Cross-border comparison of the admission prevalence and clonal structure of meticillin-resistant Staphylococcus aureus. J Hosp Infect. 2009;71:320-326.
34. Lo WT, Lin WJ, Tseng MH, et al. Nasal carriage of a single clone of community-acquired methicillin-resistant Staphylococcus aureus among kindergarten attendees in northern Taiwan. BMC Infect Dis. 2007;7:51.
35. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis. 2003;9:978-984.
36. Wertheim HF, Melles DC, Vos MC, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751-762.
37. Hisata K, Kuwahara-Arai K, Yamanoto M, et al. Dissemination of methicillin-resistant staphylococci among healthy Japanese children. J Clin Microbiol. 2005;43:3364-3372.
38. Chambers HF. Community-associated MRSA-Resistance and virulence converge. N Engl J Med. 2005;352:1485-1487.
39. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436-1444.
40. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med. 2005;352:468-475.
41. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol. 2002;40:4289-4294.
42. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 2001;32:S114-S132.
43. Udo EE, Pearman JW, Grubb WB. Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect. 1993;25:97-108.
44. Nimmo GR, Coombs GW, Pearson JC, et al. Methicillin-resistant Staphylococcus aureus in the Australian community: An evolving epidemic. Med J Aust. 2006;184:384-388.
45. Tristan A, Bes M, Meugnier H, et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis. 2007;13:594-600.
46. Hospital-associated transmission of Panton-Valentine leukocidin (PVL) positive community-associated MRSA in the West Midlands 2006. CDR Weekly. 2006. Available at: www.hpa.org.uk/cdr/archives/2006/cdr5006.pdf. Accessed December 14, 2006.
47. Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819-1827.
48. Ferry T, Thomas D, Genestier AL, et al. Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis. 2005;41:771-777.
49. Eckhardt C, Halvosa JS, Ray SM, et al. Transmission of methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit from a patient with community-acquired disease. Infect Control Hosp Epidemiol. 2003;24:460-461.
50. Linde H, Wagenlehner F, Strommenger B, et al. Healthcare-associated outbreaks and community-acquired infections due to MRSA carrying the Panton-Valentine leucocidin gene in southeastern Germany. Eur J Clin Microbiol Infect Dis. 2005;24:419-422.
51. Chini V, Petinaki E, Foka A, et al. Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece. Clin Microbiol Infect. 2006;12:29-34.
52. Monecke S, Berger-Bächi B, Coombs G, et al. Comparative genomics and DNA array-based genotyping of pandemic Staphylococcus aureus strains encoding Panton-Valentine leukocidin. Clin Microbiol Infect. 2007;13:236-249.